Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-19

Clinical Trial Update: The Pharmacokinetics Study of Fotagliptin in Patients with Different Degrees of Renal Insufficiency [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetics study evaluating Fotagliptin in patients with Type 2 Diabetes Mellitus across different degrees of renal insufficiency has been compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fotagliptin (fotagliptin)

Snippet

Sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd. | Conditions: Type 2 Diabetes Mellitus (T2DM), Renal Insuficiency | Phase 1 | Status: COMPLETED